GlassScriptPhysician profile
Timothy P Amann
NPI 1467593228
$7,415.52
in general payments reported to CMS, 2019-2025
12 companies · $5,030 in 2025
The $5,030 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.16 · 2021: $47.35 · 2022: $44.64 · 2023: $2,087 · 2024: $150 · 2025: $5,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,918 · Travel and Lodging: $1,590 · Food and Beverage: $982 · Debt Forgiveness: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,918.48 |
| Travel and Lodging | $1,590.36 |
| Food and Beverage | $982.34 |
| Debt Forgiveness | $776.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,986.94 | 2025 | Inhance |
| Arthrex, INC. | $1,069.96 | 2023 | |
| Paladin Technology Solutions | $988.73 | 2023 | |
| Olympus America INC. | $776.19 | 2025 | |
| Stryker Corporation | $158.35 | 2025 | Insignia |
| Smith+Nephew, INC. | $141.09 | 2019-2025 | 660hd-E Image Management System, Lens 4k, N/A |
| Depuy Synthes Sales INC. | $117.08 | 2024 | |
| Hologic Sales and Service, LLC | $77.26 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $52.62 | 2023-2025 | Gel-One Cross-Linked Hyaluronate |
| Sanara Medtech INC. | $20.46 | 2025 | Celleraterx |
| Horizon Therapeutics Plc | $14.85 | 2019 | |
| Heraeus Medical, LLC. | $11.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Amann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.